Sorry Bill, Herbalife's woes aren't about you

Controversial supplements company Herbalife disappointed investors with weaker-than-expected earnings and cautious guidance. But nobody was talking about short seller Bill Ackman.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.